NCT02779855 2026-03-10
Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 1/2 Completed
H. Lee Moffitt Cancer Center and Research Institute
Alliance Foundation Trials, LLC.
University of Washington
University of Miami
Stanford University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
St. Joseph Hospital of Orange
Abramson Cancer Center at Penn Medicine
University of Pennsylvania